MyAverix Finance
HK · Healthcare
China Isotope Radiation Corporation (1763)
Medical Devices
China Isotope Radiation Corporation (1763) is listed on HK in the Healthcare sector. Industry: Medical Devices. As of 2026-05-21, reported market cap is $5.78B, P/E ratio is 15.44, net margin is 4.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1763
China Isotope Radiation Corporation (1763) — FAQ
What is China Isotope Radiation Corporation's market cap?
China Isotope Radiation Corporation (1763) has a reported market cap of $5.78B (data as of 2026-05-21).
What is 1763's P/E ratio?
The price-to-earnings (P/E) ratio for China Isotope Radiation Corporation (1763) is 15.44 (data as of 2026-05-21).
Does China Isotope Radiation Corporation pay a dividend?
Dividend yield is not available in the current snapshot for China Isotope Radiation Corporation (1763). Check the MyAverix Finance app for the latest dividend data.
What sector is China Isotope Radiation Corporation in?
China Isotope Radiation Corporation (1763) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 1763 listed on?
1763 is listed on HK.
What is China Isotope Radiation Corporation's net margin?
China Isotope Radiation Corporation (1763) reports a net margin of 4.6% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.